XL092 (Synonyms: XL092) |
カタログ番号GC62266 |
XL092 は、MET、VEGFR2、AXL、MER を含む複数の受容体チロシンキナーゼ (RTK) の経口活性型 ATP 競合阻害剤であり、細胞ベースのアッセイでの IC50 はそれぞれ 15 nM、1.6 nM、3.4 nM、7.2 nM です。 XL092 は抗腫瘍活性を示します。 XL092 は、キナーゼ依存性疾患および病態研究の可能性を秘めています。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2367004-54-2
Sample solution is provided at 25 µL, 10mM.
XL092 is a potent inhibitor of the activity of Axl, Mer and C-Met kinase with IC50s of <10 nM, respectively. XL092 exhibits anti-tumor activity and has the potential for kinase-dependent diseases and conditions research[1].
XL092 (compound 8; 3 mg/kg; iv) has a T1/2 of 5.4 hours, a CL of 43 mL/hr•kg. XL092 (3 mg/kg; po) has a T1/2 of 7.1 hours and a Cmax of 11.4 μM for rats[1].
[1]. Lynne Canne Bannen, et al. Compounds for the treatment of kinase-dependent disorders. WO2019148044A1.
Average Rating: 5
(Based on Reviews and 37 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *